Cystic Fibrosis Canada Achieves Reaccreditation from Imagine Canada’s Standard Program
TORONTO (March 10, 2022) – Cystic Fibrosis Canada today announces that it has achieved reaccreditation under Imagine Canada’s Standards Program, being an accredited member of the Standard Program since October 1st, 2015. Accredited organizations are required to complete full reaccreditation on a five-year basis. With this achievement, Cystic Fibrosis Canada remains a distinguished member of the ever-growing community of 250+ nonprofit organizations dedicated to operational excellence.
The Standards Program is a Canada-wide set of shared standards for charities and nonprofits designed to help organizations strengthen their operations in five fundamental areas: board governance; financial accountability and transparency; fundraising, staff management and volunteer involvement. The Standards Program is the only national accreditation program that is designed for all Canadian charities and nonprofits and is a sought-after hallmark of excellence within the charitable sector for funders, donors, sponsors, and supporters alike.
"We are pleased to achieve consecutive accreditations from the Imagine Canada Standards Program,” said Kelly Grover, President and CEO, Cystic Fibrosis Canada. "It is hugely important to us that our donors give with confidence knowing that we have met the stringent standards set out across the five categories.”
“Earning the accreditation, especially in these changing times, shows remarkable resilience, and a strong commitment to innovation and excellence. We commend the latest well-deserving recipients of the Trustmark for achieving Imagine Canada’s Standards accreditation and demonstrating outstanding adherence to sound governance.” -Bruce MacDonald, President and CEO of Imagine Canada.
About the Standards Program
The goals of Imagine Canada’s Standards Program are to increase organizational excellence and transparency of charities and nonprofits, to build resilience and to strengthen public confidence in individual organizations and the sector as a whole. To earn the accreditation, organizations must meet 72 standards in financial management and accountability, fundraising practice, board governance, staff management, and volunteer management.
Peer-review Process and Compliance
Cystic Fibrosis Canada’s policies and procedures in the five areas of compliance were evaluated by a group of volunteers from the sector and were found to be compliant with the Standards Program. Accredited organizations are required to complete full re-accreditation on a five-year basis. Compliance during the accreditation period is monitored regularly and requires organizations to submit evidence demonstrating selected standards are being met.
- 30 -
About Cystic Fibrosis
Cystic fibrosis is the most common fatal genetic disease affecting Canadian children and young adults. There is no cure. Of the Canadians with cystic fibrosis who died in the past three years, half were under the age of 34. Cystic fibrosis is a progressive, degenerative multi-system disease that affects mainly the lungs and digestive system. In the lungs, where the effects are most devastating, a build-up of thick mucus causes severe respiratory problems. Mucus and protein also build up in the digestive tract, making it difficult to digest and absorb nutrients from food. In addition to the physical effects of the disease, mental health concerns are emerging; anxiety and depression are common among this population. Double lung transplants are the final option for patients with end-stage disease; most fatalities of people with cystic fibrosis are due to lung disease.
About Cystic Fibrosis Canada
Cystic Fibrosis Canada has dramatically changed the cystic fibrosis story. We have advanced research and care that has more than doubled life expectancy. Since being founded by parents in 1960, Cystic Fibrosis Canada has grown into a leading organization with a central role engaging people living with cystic fibrosis, parents and caregivers, volunteers, researchers, and healthcare professionals, government, and donors. We work together to change lives for the 4,332 Canadian children and adults living with cystic fibrosis through treatments, research, information, and support. Despite our remarkable progress together, we are not yet done. Not when half of the Canadians with cystic fibrosis who died in the past three years were under the age of 34. We will keep pushing, keep going further until all people with cystic fibrosis can and do experience everything life has to offer —and enjoy everything life has to offer.
For more information, please contact:
Nicole Young, Director, Corporate Communications
Tel: 905 317-5529
Magdelena Oksam, Marketing and Communications Coordinator